Skip to main content
. 2023 Jan 7;37:103324. doi: 10.1016/j.nicl.2023.103324

Table 1.

Demographics and baseline characteristics of participants with autism spectrum disorder of the adequate diffusion MRI data quality across baseline, week 4, and week 8.

Active-Active
(n = 22)
Sham-Active
(n = 27)
P value
Age (years), mean (S.D.) 13.0 (3.2) 12.9 (2.8) 0.939
Male, n (%) 18 (82) 23 (85) 0.751
RMSt1 (mm), mean (S.D.) 0.316 (0.163) 0.331 (0.220) 0.976
Total outlierst1 (%), mean (S.D.) 0.98 (0.86) 1.07 (0.83) 0.482
RMSt2 (mm), mean (S.D.) 0.326 (0.261) 0.226 (0.062) 0.164
Total outlierst2 (%), mean (S.D.) 0.92 (0.73) 0.70 (0.40) 0.340
RMSt3 (mm), mean (S.D.) 0.334 (0.212) 0.238 (0.107) 0.090
Total outlierst3 (%), mean (S.D.) 1.01 (0.79) 0.85 (0.87) 0.433
ICVt1 (cm3), mean (S.D.) 1440.1 (144.1) 1409.4 (106.5) 0.396
pSTS/motor proportion of NormE (%), mean (S.D.) 78.6 (7.7) 76.5 (11.3) 0.447
Intelligence quotient (IQ), mean (S.D.)
Full intelligence 91.1 (18.2) 88.1 (14.3) 0.519
Verbal Comprehension index 90.2 (19.0) 90.1 (17.2) 0.976
Perceptual Reasoning Index 101.9 (22.3) 90.4 (22.8) 0.083
Working Memory Index 93.8 (19.3) 89.1 (15.8) 0.360
Processing Speed Index 82.8 (16.0) 85.4 (23.8) 0.659
Social Responsiveness Scale, mean (S.D.) 105.8 (22.9) 99.0 (20.5) 0.278
Repetitive Behavior Scale-Revised, mean (S.D.) 34.4 (20.0) 32.7 (20.7) 0.770
Comorbidity with ADHD, n (%) 13 (59) 9 (33) 0.071
Medication, n (%)
Methylphenidate 8 (36) 5 (19) 0.159
Atomoxetine 1 (5) 1 (4) 0.882
Antipsychotics 1 (5) 3(11) 0.404

Acronyms: S.D. – standard deviation; RMS – relative Root-Mean-Square framewise displacement during diffusion MRI; pSTS – posterior superior temporal sulcus; NormE – normalized induced electric field; ICV – Intra-Cranial Volume.